Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
24 7월 2024 - 5:00AM
Business Wire
Johnson & Johnson (NYSE: JNJ) will participate in the Morgan
Stanley 22nd Annual Global Healthcare Conference on Wednesday,
September 4th, held at the New York Marriott Marquis, New York, NY.
Joaquin Duato, Chairman and Chief Executive Officer and John Reed,
Executive Vice President, Innovative Medicine, R&D will
represent the Company in a session scheduled at 10:45 am (Eastern
Time).
This live audio webcast will be available to investors and other
interested parties by accessing the Johnson & Johnson website
at www.investor.jnj.com.
The audio webcast replay will be available approximately 48-hrs
after the webcast.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240723451320/en/
Media contact: media-relations@its.jnj.com Investor
contact: investor-relations@its.jnj.com
Johnson and Johnson (NYSE:JNJ)
과거 데이터 주식 차트
부터 7월(7) 2024 으로 8월(8) 2024
Johnson and Johnson (NYSE:JNJ)
과거 데이터 주식 차트
부터 8월(8) 2023 으로 8월(8) 2024
